Skip to main content
Top
Published in: Osteoporosis International 1/2017

01-01-2017 | Original Article

The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model

Authors: M. Chakhtoura, W. D. Leslie, M. McClung, A. M. Cheung, G. El-Hajj Fuleihan

Published in: Osteoporosis International | Issue 1/2017

Login to get access

Abstract

Summary

We describe our approach to develop FRAX-based osteoporosis treatment guidelines in Lebanon, a country with low-moderate fracture rates. A hybrid assessment algorithm that combines a fixed 10 % intervention threshold until age 70 years, and an age-dependent threshold thereafter, was deemed most suitable.

Introduction

The FRAX risk calculator is used to guide intervention thresholds in several national osteoporosis guidelines. This study aimed to describe the approach in developing FRAX-based osteoporosis treatment guidelines in Lebanon, a country with relatively low fracture rates.

Methods

We reassessed previous national guidelines combined with an evaluation of age-dependent and fixed FRAX-based intervention threshold models used in the UK, the USA, and Canada. We took into consideration the risk for major osteoporotic fractures (MOF) and the proportions of subjects considered for therapy using such thresholds, before finalizing a model for Lebanon.

Results

The new Lebanese guidelines retained the recommendation to treat individuals with fragility fracture at the hip or spine. A femoral neck T-score ≤−2.5 in subjects without fractures was dropped, since it would imply consideration of therapy for individuals with a 10-year risk for MOF of <10 %, up to age 75 years in women. After considering the impact of both age-dependent and fixed intervention thresholds, we chose a new hybrid algorithm, combining a fixed 10 % treatment threshold until age 70 years and an age-dependent threshold thereafter.

Conclusion

The Lebanese FRAX-based hybrid model takes into consideration the risk for MOF and the proportions of subjects considered for treatment. This model avoids consideration of drug therapy in a large proportion of younger subjects at low risk for fracture and targets high risk elderly individuals. It was deemed most suitable for Lebanon and may be an option for other countries with relatively low fracture rates.
Appendix
Available only for authorised users
Literature
1.
go back to reference Johnell O, Kanis J (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733CrossRefPubMed Johnell O, Kanis J (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733CrossRefPubMed
2.
go back to reference Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254–1259CrossRefPubMedPubMedCentral Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254–1259CrossRefPubMedPubMedCentral
3.
go back to reference Melton LJ, Atkinson EJ, O’Fallon WM, Wahner HW, Riggs BL (1993) Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 8(10):1227–1233CrossRefPubMed Melton LJ, Atkinson EJ, O’Fallon WM, Wahner HW, Riggs BL (1993) Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 8(10):1227–1233CrossRefPubMed
4.
go back to reference Baddoura R, Arabi A, Haddad-Zebouni S, Khoury N, Salamoun M, Ayoub G, Okais J, Awada H, El-Hajj Fuleihan G (2007) Vertebral fracture risk and impact of database selection on identifying elderly Lebanese with osteoporosis. Bone 40(4):1066–1072CrossRefPubMed Baddoura R, Arabi A, Haddad-Zebouni S, Khoury N, Salamoun M, Ayoub G, Okais J, Awada H, El-Hajj Fuleihan G (2007) Vertebral fracture risk and impact of database selection on identifying elderly Lebanese with osteoporosis. Bone 40(4):1066–1072CrossRefPubMed
5.
go back to reference Cauley JA, Chalhoub D, Kassem AM, El-Hajj Fuleihan G (2014) Geographic and ethnic disparities in osteoporotic fractures. Nat Rev Endocrinol 10(6):338–351CrossRefPubMed Cauley JA, Chalhoub D, Kassem AM, El-Hajj Fuleihan G (2014) Geographic and ethnic disparities in osteoporotic fractures. Nat Rev Endocrinol 10(6):338–351CrossRefPubMed
6.
go back to reference Sibai A, Nasser W, Ammar W, Khalife M, Harb H, El-Hajj Fuleihan G (2011) Hip fracture incidence in Lebanon: a national registry-based study with reference to standardized rates worldwide. Osteoporos Int 22(9):2499–2506CrossRefPubMed Sibai A, Nasser W, Ammar W, Khalife M, Harb H, El-Hajj Fuleihan G (2011) Hip fracture incidence in Lebanon: a national registry-based study with reference to standardized rates worldwide. Osteoporos Int 22(9):2499–2506CrossRefPubMed
7.
go back to reference Kanis J, Odén A, McCloskey E, Johansson H, Wahl DA, Cooper C (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23(9):2239–2256CrossRefPubMedPubMedCentral Kanis J, Odén A, McCloskey E, Johansson H, Wahl DA, Cooper C (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23(9):2239–2256CrossRefPubMedPubMedCentral
8.
go back to reference Kanis J, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A (2002) Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30(1):251–258CrossRefPubMed Kanis J, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A (2002) Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30(1):251–258CrossRefPubMed
9.
go back to reference Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston J, Dawson-Hughes B, El Hajj Fuleihan G (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22(9):2395–2411CrossRefPubMed Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston J, Dawson-Hughes B, El Hajj Fuleihan G (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22(9):2395–2411CrossRefPubMed
10.
go back to reference Kanis J, Odén A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18(8):1033–1046CrossRefPubMed Kanis J, Odén A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18(8):1033–1046CrossRefPubMed
11.
go back to reference Rubin KH, Friis-Holmberg T, Hermann AP, Abrahamsen B, Brixen K (2013) Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. J Bone Miner Res 28(8):1701–1717CrossRefPubMed Rubin KH, Friis-Holmberg T, Hermann AP, Abrahamsen B, Brixen K (2013) Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. J Bone Miner Res 28(8):1701–1717CrossRefPubMed
12.
go back to reference Kanis J, Johnell O, Odén A, Johansson H, McCloskey E (2008) FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385–397CrossRefPubMedPubMedCentral Kanis J, Johnell O, Odén A, Johansson H, McCloskey E (2008) FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385–397CrossRefPubMedPubMedCentral
15.
go back to reference Svedbom A, Hernlund E, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey E, Jönsson B, Kanis J (2013) Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos 8(1–2):1–218 Svedbom A, Hernlund E, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey E, Jönsson B, Kanis J (2013) Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos 8(1–2):1–218
16.
go back to reference Compston J, Cooper A, Cooper C, Francis R, Kanis J, Marsh D, McCloskey E, Reid D, Selby P, Wilkins M (2009) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 62(2):105–108CrossRefPubMed Compston J, Cooper A, Cooper C, Francis R, Kanis J, Marsh D, McCloskey E, Reid D, Selby P, Wilkins M (2009) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 62(2):105–108CrossRefPubMed
18.
go back to reference Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182(17):1864–1873CrossRefPubMedPubMedCentral Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182(17):1864–1873CrossRefPubMedPubMedCentral
19.
go back to reference Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R, Kanis J, Marsh D, McCloskey E, Reid D (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas 75(4):392–396CrossRefPubMed Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R, Kanis J, Marsh D, McCloskey E, Reid D (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas 75(4):392–396CrossRefPubMed
20.
go back to reference Kanis J, McCloskey E, Johansson H, Strom O, Borgstrom F, Odén A (2008) Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK. Osteoporos Int 19(10):1395–1408CrossRefPubMed Kanis J, McCloskey E, Johansson H, Strom O, Borgstrom F, Odén A (2008) Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK. Osteoporos Int 19(10):1395–1408CrossRefPubMed
21.
go back to reference Cosman F, De Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S, Lindsay R (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381CrossRefPubMedPubMedCentral Cosman F, De Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S, Lindsay R (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381CrossRefPubMedPubMedCentral
22.
go back to reference Tosteson A, Burge RT, Marshall DA, Lindsay R (2008) Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations. Am J Manag Care 14(9):605–615PubMed Tosteson A, Burge RT, Marshall DA, Lindsay R (2008) Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations. Am J Manag Care 14(9):605–615PubMed
23.
go back to reference El-Hajj Fuleihan G, Baddoura R, Awada H, Okais J, Rizk P, McClung M (2005) Lebanese guidelines for osteoporosis assessment and treatment: who to test? What measures to use? When to treat? J Clin Densitom 8(2):148–163CrossRef El-Hajj Fuleihan G, Baddoura R, Awada H, Okais J, Rizk P, McClung M (2005) Lebanese guidelines for osteoporosis assessment and treatment: who to test? What measures to use? When to treat? J Clin Densitom 8(2):148–163CrossRef
24.
go back to reference El-Hajj Fuleihan G, Baddoura R, Awada H, Arabi A, Okais J (2007) First update of the Lebanese guidelines for osteoporosis assessment and treatment. J Med Liban 55(4):1–7 El-Hajj Fuleihan G, Baddoura R, Awada H, Arabi A, Okais J (2007) First update of the Lebanese guidelines for osteoporosis assessment and treatment. J Med Liban 55(4):1–7
27.
go back to reference Kreidieh OI, El-Hajj Fuleihan G (2014) Impact of changes in mortality on FRAX-derived fracture probabilities. Bone 62:43–50CrossRefPubMed Kreidieh OI, El-Hajj Fuleihan G (2014) Impact of changes in mortality on FRAX-derived fracture probabilities. Bone 62:43–50CrossRefPubMed
28.
go back to reference Sibai AM, Hwalla N, Adra N, Rahal B (2003) Prevalence and covariates of obesity in Lebanon: findings from the first epidemiological study. Obes research 11(11):1353–1361CrossRef Sibai AM, Hwalla N, Adra N, Rahal B (2003) Prevalence and covariates of obesity in Lebanon: findings from the first epidemiological study. Obes research 11(11):1353–1361CrossRef
29.
go back to reference Sibai AM, Obeid O, Batal M, Adra N, El Khoury D, Hwalla N (2008) Prevalence and correlates of metabolic syndrome in an adult Lebanese population. CVD Prev Control 3(2):83–90CrossRef Sibai AM, Obeid O, Batal M, Adra N, El Khoury D, Hwalla N (2008) Prevalence and correlates of metabolic syndrome in an adult Lebanese population. CVD Prev Control 3(2):83–90CrossRef
30.
go back to reference Ballane G, Cauley JA, Arabi A, El-Hajj Fuleihan G (2013) Geographic variability in hip and vertebral fractures. In: Robert Marcus ML, David Demspter, and Jane Cauley. (ed) Osteporosis, Fourth Edition, Elsevier, Chapter 27 Ballane G, Cauley JA, Arabi A, El-Hajj Fuleihan G (2013) Geographic variability in hip and vertebral fractures. In: Robert Marcus ML, David Demspter, and Jane Cauley. (ed) Osteporosis, Fourth Edition, Elsevier, Chapter 27
31.
go back to reference Kanis JA, Johansson H, Odén A, McCloskey EV (2012) The distribution of FRAX®-based probabilities in women from Japan. J Bone Miner Res 30(6):700–705CrossRef Kanis JA, Johansson H, Odén A, McCloskey EV (2012) The distribution of FRAX®-based probabilities in women from Japan. J Bone Miner Res 30(6):700–705CrossRef
32.
go back to reference Bliuc D, Nguyen TV, Eisman JA, Center JR (2013) The impact of nonhip nonvertebral fractures in elderly women and men. J Clin Endocrinol Metab 99(2):415–423CrossRefPubMed Bliuc D, Nguyen TV, Eisman JA, Center JR (2013) The impact of nonhip nonvertebral fractures in elderly women and men. J Clin Endocrinol Metab 99(2):415–423CrossRefPubMed
33.
go back to reference Morin S, Lix L, Leslie WD (2014) The importance of previous fracture site on osteoporosis diagnosis and incident fractures in women. J Bone Miner Res 29(7):1675–1680CrossRefPubMed Morin S, Lix L, Leslie WD (2014) The importance of previous fracture site on osteoporosis diagnosis and incident fractures in women. J Bone Miner Res 29(7):1675–1680CrossRefPubMed
34.
go back to reference FitzGerald G, Compston JE, Chapurlat RD, Pfeilschifter J, Cooper C, Hosmer DW, Adachi JD, Anderson FA, Díez-Pérez A, Greenspan SL (2014) Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW. J Clin Endocrinol Metab 99(3):817–826CrossRefPubMed FitzGerald G, Compston JE, Chapurlat RD, Pfeilschifter J, Cooper C, Hosmer DW, Adachi JD, Anderson FA, Díez-Pérez A, Greenspan SL (2014) Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW. J Clin Endocrinol Metab 99(3):817–826CrossRefPubMed
35.
go back to reference Kanis J (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 4(6):368–381CrossRefPubMed Kanis J (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 4(6):368–381CrossRefPubMed
36.
go back to reference Brown JP, Josse RG, Scientific Advisory Council of the Osteoporosis Society of Canada (2002) 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167(10 suppl):S1–S34PubMedPubMedCentral Brown JP, Josse RG, Scientific Advisory Council of the Osteoporosis Society of Canada (2002) 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167(10 suppl):S1–S34PubMedPubMedCentral
37.
go back to reference Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW, Johnston C Jr, Kleerekoper M, Lindsay R, Luckey MM (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 9(6):544–564CrossRefPubMed Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW, Johnston C Jr, Kleerekoper M, Lindsay R, Luckey MM (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 9(6):544–564CrossRefPubMed
38.
go back to reference Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ 3rd, O’Neill T, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20(7):1185–1194CrossRefPubMed Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ 3rd, O’Neill T, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20(7):1185–1194CrossRefPubMed
40.
go back to reference Nguyen N, Frost S, Center J, Eisman J, Nguyen T (2008) Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 19(10):1431–1444CrossRefPubMed Nguyen N, Frost S, Center J, Eisman J, Nguyen T (2008) Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 19(10):1431–1444CrossRefPubMed
41.
go back to reference Briot K, Cortet B, Thomas T, Audran M, Blain H, Breuil V, Chapuis L, Chapurlat R, Fardellone P, Feron J-M (2012) 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. Joint Bone Spine 79(3):304–313CrossRefPubMed Briot K, Cortet B, Thomas T, Audran M, Blain H, Breuil V, Chapuis L, Chapurlat R, Fardellone P, Feron J-M (2012) 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. Joint Bone Spine 79(3):304–313CrossRefPubMed
43.
go back to reference Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi K, Endo N, Ohta H, Shiraki M, Sugimoto T, Suzuki T (2012) Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary. Arch Osteoporos 7(1–2):3–20CrossRefPubMedPubMedCentral Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi K, Endo N, Ohta H, Shiraki M, Sugimoto T, Suzuki T (2012) Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary. Arch Osteoporos 7(1–2):3–20CrossRefPubMedPubMedCentral
44.
go back to reference Zhang Z, Ou Y, Sheng Z, Liao E (2014) How to decide intervention thresholds based on FRAX in central south Chinese postmenopausal women. Endocrine 45(2):195–197CrossRefPubMed Zhang Z, Ou Y, Sheng Z, Liao E (2014) How to decide intervention thresholds based on FRAX in central south Chinese postmenopausal women. Endocrine 45(2):195–197CrossRefPubMed
45.
go back to reference Ip I, Cheung S, Cheung T, Choi T, Chow S, Ho Y, Kan S, Kung W, Lee K, Leung K (2013) The Osteoporosis Society of Hong Kong (OSHK): 2013 OSHK guideline for clinical management of postmenopausal osteoporosis in Hong Kong. Hong Kong Med J 19(Suppl 2):1–40PubMed Ip I, Cheung S, Cheung T, Choi T, Chow S, Ho Y, Kan S, Kung W, Lee K, Leung K (2013) The Osteoporosis Society of Hong Kong (OSHK): 2013 OSHK guideline for clinical management of postmenopausal osteoporosis in Hong Kong. Hong Kong Med J 19(Suppl 2):1–40PubMed
46.
go back to reference Głuszko P, Lorenc RS, Karczmarewicz E, Misiorowski W, Jaworski M (2013) Polish guidelines for the diagnosis and management of osteoporosis: a review of 2013 update. Pol Arch Med Wewn 124(5):255–263 Głuszko P, Lorenc RS, Karczmarewicz E, Misiorowski W, Jaworski M (2013) Polish guidelines for the diagnosis and management of osteoporosis: a review of 2013 update. Pol Arch Med Wewn 124(5):255–263
47.
go back to reference Lippuner K, Johansson H, Borgström F, Kanis J, Rizzoli R (2012) Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland. Osteoporos Int 23(11):2579–2589CrossRefPubMed Lippuner K, Johansson H, Borgström F, Kanis J, Rizzoli R (2012) Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland. Osteoporos Int 23(11):2579–2589CrossRefPubMed
48.
go back to reference Chen JS, Simpson JM, Blyth FM, March LM (2014) Managing osteoporosis with FRAX® in Australia: proposed new treatment thresholds from the 45 & Up Study cohort. Bone 69:148–153CrossRefPubMed Chen JS, Simpson JM, Blyth FM, March LM (2014) Managing osteoporosis with FRAX® in Australia: proposed new treatment thresholds from the 45 & Up Study cohort. Bone 69:148–153CrossRefPubMed
49.
go back to reference Johansson H, Kanis J, McCloskey E, Odén A, Devogelaer JP, Kaufman JM, Neuprez A, Hiligsmann M, Bruyère O, Reginster J-Y (2011) A FRAX® model for the assessment of fracture probability in Belgium. Osteoporos Int 22(2):453–461CrossRefPubMed Johansson H, Kanis J, McCloskey E, Odén A, Devogelaer JP, Kaufman JM, Neuprez A, Hiligsmann M, Bruyère O, Reginster J-Y (2011) A FRAX® model for the assessment of fracture probability in Belgium. Osteoporos Int 22(2):453–461CrossRefPubMed
50.
go back to reference Goff D, Lloyd-Jones D, Bennett G (2014) American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:2935–2959CrossRefPubMed Goff D, Lloyd-Jones D, Bennett G (2014) American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:2935–2959CrossRefPubMed
51.
go back to reference Rabar S, Harker M, O’Flynn N, Wierzbicki AS (2014) Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. BMJ 349:g4356CrossRefPubMed Rabar S, Harker M, O’Flynn N, Wierzbicki AS (2014) Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. BMJ 349:g4356CrossRefPubMed
52.
go back to reference McCloskey E, Kanis J, Johansson H, Harvey N, Oden A, Cooper A, Cooper C, Francis R, Reid D, Marsh D (2015) FRAX-based assessment and intervention thresholds—an exploration of thresholds in women aged 50 years and older in the UK. Osteoporos Int 26(8):2091–2099CrossRefPubMed McCloskey E, Kanis J, Johansson H, Harvey N, Oden A, Cooper A, Cooper C, Francis R, Reid D, Marsh D (2015) FRAX-based assessment and intervention thresholds—an exploration of thresholds in women aged 50 years and older in the UK. Osteoporos Int 26(8):2091–2099CrossRefPubMed
53.
go back to reference Siggeirsdottir K, Aspelund T, Johansson H, Gudmundsson EF, Mogensen B, Jonsson BY, Gudnason V, McCloskey E, Oden A, Sigurdsson G, Kanis JA (2014) The incidence of a first major osteoporotic fracture in Iceland and implications for FRAX. Osteoporos Int 25:2445–2451CrossRefPubMed Siggeirsdottir K, Aspelund T, Johansson H, Gudmundsson EF, Mogensen B, Jonsson BY, Gudnason V, McCloskey E, Oden A, Sigurdsson G, Kanis JA (2014) The incidence of a first major osteoporotic fracture in Iceland and implications for FRAX. Osteoporos Int 25:2445–2451CrossRefPubMed
54.
go back to reference Tosteson A, Melton L III, Dawson-Hughes B, Baim S, Favus M, Khosla S, Lindsay L (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19:437–447CrossRefPubMedPubMedCentral Tosteson A, Melton L III, Dawson-Hughes B, Baim S, Favus M, Khosla S, Lindsay L (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19:437–447CrossRefPubMedPubMedCentral
55.
go back to reference Makras P, Athanasakis K, Boubouchairopoulou N, Rizou S, Anastasilakis A, Kyriopoulos J, Lyritis G (2015) Cost-effective osteoporosis treatment thresholds in Greece. Osteoporos Int 26(7):1949–1957CrossRefPubMed Makras P, Athanasakis K, Boubouchairopoulou N, Rizou S, Anastasilakis A, Kyriopoulos J, Lyritis G (2015) Cost-effective osteoporosis treatment thresholds in Greece. Osteoporos Int 26(7):1949–1957CrossRefPubMed
56.
go back to reference Marques A, Ferreira RJ, Santos E, Loza E, Carmona L, da Silva JAP (2015) The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis. Ann Rheum Dis 74(11):1958–1967CrossRefPubMed Marques A, Ferreira RJ, Santos E, Loza E, Carmona L, da Silva JAP (2015) The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis. Ann Rheum Dis 74(11):1958–1967CrossRefPubMed
57.
go back to reference Cheung E, Kung AW, Tan KC (2014) Outcomes of applying the NOF, NOGG and Taiwanese guidelines to a cohort of Chinese early postmenopausal women. Clin Endocrinol 80(2):200–207CrossRef Cheung E, Kung AW, Tan KC (2014) Outcomes of applying the NOF, NOGG and Taiwanese guidelines to a cohort of Chinese early postmenopausal women. Clin Endocrinol 80(2):200–207CrossRef
58.
go back to reference Bolland MJ, Grey A (2010) Disparate outcomes from applying UK and US osteoporosis treatment guidelines. J Clin Endocrinol Metab 95(4):1856–1860CrossRefPubMed Bolland MJ, Grey A (2010) Disparate outcomes from applying UK and US osteoporosis treatment guidelines. J Clin Endocrinol Metab 95(4):1856–1860CrossRefPubMed
Metadata
Title
The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model
Authors
M. Chakhtoura
W. D. Leslie
M. McClung
A. M. Cheung
G. El-Hajj Fuleihan
Publication date
01-01-2017
Publisher
Springer London
Published in
Osteoporosis International / Issue 1/2017
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-016-3766-5

Other articles of this Issue 1/2017

Osteoporosis International 1/2017 Go to the issue